To determine the role of PKR on breast cancer cell response to chemotherapy agents, MCF7, T-47D and MDA-MB-231 cells expressing either siRNA to PKR or control siRNA were treated with doxorubicin (DOX) and viability was measured by Trypan blue dye exclusion assay. Here, EIF2AK2 is linked to breast carcinoma.